China Shenghuo Announces Receipt of Deficiency Notice and Voluntary Delisting from NYSE Amex LLC and Deregistration with the SEC
KUNMING, China, May 7, 2012 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex LLC: KUN) ("China Shenghuo" or the "Company"), today announced its intent not to file Form 15 at this time and continue to be a reporting company until such time as it is allowed to sus...
China Shenghuo Announces Its Intent Not to File Form 15 At This Time and Continue to be a Reporting Company Until Such Time As It Is Allowed to Suspend Its Reporting Obligations
KUNMING, China, May 7, 2012 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex LLC: KUN) (“China Shenghuo” or the “Company”), today announced its intent not to file Form 15 at this time and continue to be a reporting company until such time as it is allowed to suspend its r...
China Shenghuo Announces Receipt of Deficiency Notice and Voluntary Delisting from NYSE Amex LLC and Deregistration with the SEC
KUNMING, China, April 20, 2012 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex LLC: KUN) ("China Shenghuo" or the "Company"), today announced that on April 17, 2012, it received a deficiency letter (the "Deficiency Letter") from the NYSE Amex LLC ("AMEX") stati...
China Shenghuo Pharmaceutical Receives Opinion with Going Concern Qualification from its Auditor
KUNMING, China, April 5, 2012 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex: KUN) ("China Shenghuo" or the "Company"), today announced that its audited consolidated financial statements for the fiscal year ended December 31, 2011, included in the Company's An...
China Shenghuo Pharmaceutical Reports Financial Results for the Full Year 2011
KUNMING, China, March 30, 2012 /PRNewswire/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today reported financial results for the year ended December 31, 2011. Full Year 2011 Highlights -- Total revenue was approximately $44.2 m...
China Shenghuo Pharmaceutical Reports Financial Results for the Third Quarter of 2011
KUNMING, China, Nov. 14, 2011 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today reported financial results for the third quarter ended September 30, 2011. *Third Quarter 2011** Highlights* -- Total re...
China Shenghuo Pharmaceutical Holdings, Inc. Reports Financial Results for the Second Quarter of 2011
KUNMING, China, Aug. 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today reported unaudited financial results for the second quarter ended June 30, 2011. *Second Quarter** 20**11** Highlights* ...
China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011
KUNMING, China, May 17, 2011 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today reported unaudited financial results for the first quarter ended March 31, 2011. First Quarter 2011 Highlights -- Tot...
China Shenghuo Announces New Chief Financial Officer
KUNMING, China, April 21, 2011 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), a China-based pharmaceutical company primarily engaged in the research, development, manufacture, and marketing of Traditional Chinese Medici...
China Shenghuo Pharmaceutical Reports Financial Results for the Full Year 2010
KUNMING, China, March 31, 2011 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today reported financial results for the year ended December 31, 2010. Full Year 2010 Highlights -- Total revenue was approxi...
China Shenghuo Announces Settlement Agreement for Class Action Lawsuit
KUNMING, China, March 22, 2011 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (China Shenghuo) (AMEX: KUN) announced today the final approval by the court of a settlement agreement resolving and dismissing all claims asserted against the company in the consolidated class action la...
China Shenghuo Pharmaceutical's Lixuwang Trademark Awarded Chinese Well-Known Trademark Honor
KUNMING, China, Jan. 24, 2011 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (AMEX: KUN) ("China Shenghuo" or the "Company"), a China-based pharmaceutical company engaged in the research, development, manufacture, and marketing of Traditional Chinese Medicine (TCM), nutr...
NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing
KUNMING, China, Dec. 8, 2010 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in t...
China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2010
KUNMING, China, Nov. 13, 2010 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in ...
China Shenghuo Receives Notice from NYSE Amex LLC Regarding Listing Standards
KUNMING, China, Sept. 27 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex LLC: KUN) ("China Shenghuo" or the "Company"), today announced that on September 22, 2010, it received a deficiency letter from the NYSE Amex LLC ("AMEX") stating that the Company was not in complia...
China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2010; Reaches Agreement in Principle to Settle Class Action Lawsuit
KUNMING, China, Aug. 17 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in the Pe...
China Shenghuo Reports Unaudited Financial Results for the First Quarter of 2010
KUNMING, China, May 25 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products i...
China Shenghuo Pharmaceutical Reports Financial Results for the Fourth Quarter and Full Year 2009
KUNMING, China, April 15 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE: KUN) ("China Shenghuo" or the "Company"), today reported financial results for the fourth quarter and record revenue for the year ended December 31, 2009. Fourth Quarter Highlights ...
China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009
KUNMING, China, Nov. 17 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic ...
China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009
KUNMING, China, Aug. 15 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in ...
